All news articles for September 2017

GettyImages/GOLFX

US FDA red light for Janssen’s arthritis mAb

By Flora Southey

The US FDA has rejected Janssen Biotech’s application for sirukumab, a monoclonal antibody (mAb) designed to treat severely active rheumatoid arthritis (RA).